FDA to launch advisory committee on digital health technologies
The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring.
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence.
Related News Articles
Headline
U.S. and international agencies Feb. 25 released guidance on protecting Cisco Software-defined Wide-area Networking systems from exploitation by malicious…
Headline
The Centers for Medicare & Medicaid Services Feb. 23 announced the development of its Medicare App Library. As part of the agency’s Health Technology…
Headline
The National Security Agency has released two phases of its Zero Trust Implementation Guidelines for organizations to improve their zero trust architecture.…
Headline
The Cybersecurity and Infrastructure Security Agency announced Feb. 13 that it will host a series of virtual town hall meetings to gather public input on…
Headline
John Riggi, AHA national advisor for cybersecurity and risk, talks with Brett Leatherman, FBI assistant director, Cyber Division, and Gretchen Burrier, FBI…
Headline
The AHA Feb. 9 released a series of behavioral threat assessment and management resources developed in partnership with the FBI’s Behavioral Analysis Unit-1.…